Evidence map›Paper›PMID 40533499›Full record

ArticleNPJ precision oncology2025

Applying a multi-task and multi-instance framework to predict axillary lymph node metastases in breast cancer.

Yizhi Li, Zonglin Chen, Ziyuan Ding, Danyang Mei, Zhenzhen Liu, Jia Wang, Kui Tang, Wenjun Yi, Yan Xu, Yixiong Liang and 1 more

Abstract read
In one paragraph

Article in NPJ precision oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Deep integration of clinical metadata with [European journal of nuclear medicine and molecular imaging · 2026
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Yizhi Li *Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, 410000, China.
Zonglin Chen *Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, 410000, China.
Ziyuan DingSchool of Computer Science, Central South University, Changsha, 410006, China.
Danyang MeiDepartment of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, 410000, China.
Zhenzhen LiuThe Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.
Jia WangThe Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.
Kui TangDepartment of Ultrasound Diagnosis, The Second Xiangya Hospital of Central South University, Changsha, 410000, China.
Wenjun YiDepartment of General Surgery, The Second Xiangya Hospital of Central South University, Changsha, 410000, China.
Yan XuDepartment of Ultrasound Diagnosis, The Second Xiangya Hospital of Central South University, Changsha, 410000, China.
Yixiong LiangSchool of Computer Science, Central South University, Changsha, 410006, China. yxliang@csu.edu.cn.
Yan ChengDepartment of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, 410000, China. yancheng@csu.edu.cn.

Funding

Hunan Provincial Natural Science Foundation 2022JJ80106Hunan Provincial Natural Science Foundation 2023JJ60414the National Natural Science Foundation of China 82273333the National Natural Science Foundation of China 82373064the Project of Innovation-driven Plan in Central South University 2023ZZTS0834
6 · The paper itself

Abstract

Deep learning (DL) models have shown promise in predicting axillary lymph node (ALN) status. However, most existing DL models were classification-only models and did not consider the practical application scenarios of multi-view joint prediction. Here, we propose a Multi-Task Learning (MTL) and Multi-Instance Learning (MIL) framework that simulates the real-world clinical diagnostic scenario for ALN status prediction in breast cancer. Ultrasound images of the primary tumor and ALN (if available) regions were collected, each annotated with a segmentation label. The model was trained on a training cohort and tested on both internal and external test cohorts. The proposed two-stage DL framework using one of the Transformer models, Segformer, as the network backbone, exhibits the top-performing model. It achieved an AUC of 0.832, a sensitivity of 0.815, and a specificity of 0.854 in the internal test cohort. In the external cohort, this model attained an AUC of 0.918, a sensitivity of 0.851 and a specificity of 0.957. The Class Activation Mapping method demonstrated that the DL model correctly identified the characteristic areas of metastasis within the primary tumor and ALN regions. This framework may serve as an effective second reader to assist clinicians in ALN status assessment.

Identifiers

PMID40533499
PMCPMC12177086

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.